Zalutumumab is a high-affinity fully human monoclonal antibody that targets the extracellular domain of the epidermal growth factor receptor (EGFR) and is used to treat squamous cell carcinoma of the head and neck (SCCHN).
Purity:
95.00%
CAS Number:
[667901-13-5]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted